» Articles » PMID: 22514678

Acquisition of Complement Inhibitor Serine Protease Factor I and Its Cofactors C4b-binding Protein and Factor H by Prevotella Intermedia

Overview
Journal PLoS One
Date 2012 Apr 20
PMID 22514678
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Infection with the Gram-negative pathogen Prevotella intermedia gives rise to periodontitis and a growing number of studies implies an association of P. intermedia with rheumatoid arthritis. The serine protease Factor I (FI) is the central inhibitor of complement degrading complement components C3b and C4b in the presence of cofactors such as C4b-binding protein (C4BP) and Factor H (FH). Yet, the significance of complement inhibitor acquisition in P. intermedia infection and FI binding by Gram-negative pathogens has not been addressed. Here we show that P. intermedia isolates bound purified FI as well as FI directly from heat-inactivated human serum. FI bound to bacteria retained its serine protease activity as shown in degradation experiments with (125)I-labeled C4b. Since FI requires cofactors for its activity we also investigated the binding of purified cofactors C4BP and FH and found acquisition of both proteins, which retained their activity in FI mediated degradation of C3b and C4b. We propose that FI binding by P. intermedia represents a new mechanism contributing to complement evasion by a Gram-negative bacterial pathogen associated with chronic diseases.

Citing Articles

A surface lipoprotein on binds complement factor I to promote immune evasion.

Nguyen Q, Lai C, Norris M, Ng D, Shah M, Lai C bioRxiv. 2024; .

PMID: 39484374 PMC: 11526892. DOI: 10.1101/2024.10.21.619360.


CipA mediates complement resistance of by formation of a factor I-dependent quadripartite assemblage.

Ries J, Hess M, Nouri N, Wichelhaus T, Gottig S, Falcone F Front Immunol. 2022; 13:942482.

PMID: 35958553 PMC: 9361855. DOI: 10.3389/fimmu.2022.942482.


Role of oral pathogens in the pathogenesis of intracranial aneurysm: review of existing evidence and potential mechanisms.

Hallikainen J, Keranen S, Savolainen J, Narhi M, Suominen A, Ylostalo P Neurosurg Rev. 2020; 44(1):239-247.

PMID: 32034564 PMC: 7850994. DOI: 10.1007/s10143-020-01253-y.


Composition Analysis and Feature Selection of the Oral Microbiota Associated with Periodontal Disease.

Chen W, Chang S, Tang C, Liou M, Tsai S, Lin Y Biomed Res Int. 2018; 2018:3130607.

PMID: 30581850 PMC: 6276491. DOI: 10.1155/2018/3130607.


Orthogonal test design for optimization of the extraction of essential oil from var. and evaluation of its antibacterial activity against periodontal pathogens.

Wang X, Xu F, Zhang H, Peng L, Zhen Y, Wang L 3 Biotech. 2018; 8(11):473.

PMID: 30456007 PMC: 6223414. DOI: 10.1007/s13205-018-1494-6.


References
1.
Darby I, Curtis M . Microbiology of periodontal disease in children and young adults. Periodontol 2000. 2001; 26:33-53. DOI: 10.1034/j.1600-0757.2001.2260103.x. View

2.
Blom A, Hallstrom T, Riesbeck K . Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol Immunol. 2009; 46(14):2808-17. DOI: 10.1016/j.molimm.2009.04.025. View

3.
Cunnion K, Lee J, Frank M . Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun. 2001; 69(11):6796-803. PMC: 100057. DOI: 10.1128/IAI.69.11.6796-6803.2001. View

4.
Hessing M, Vlooswijk R, Hackeng T, Kanters D, Bouma B . The localization of heparin-binding fragments on human C4b-binding protein. J Immunol. 1990; 144(1):204-8. View

5.
Meri S, Pangburn M . Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. Biochem Biophys Res Commun. 1994; 198(1):52-9. DOI: 10.1006/bbrc.1994.1008. View